Esophagogastric Adenocarcinoma
1 competing product in clinical development for Esophagogastric Adenocarcinoma.
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab deruxtecan + 5FU/LV + Trastuzumab deruxtecan + FLO | Daiichi Sankyo | Phase 1/2 | Recruiting | 39 |